Registration Link: https://events.teams.microsoft.com/event/c73f725c-d805-4a70-a452-324e7ceb63d6@37c354b2-85b0-47f5-b222-07b48d774ee3
Atrial Fibrillation (AF) is a major risk factor for stroke, and effective anticoagulation is key to reducing this risk. We are hosting two educational events focused on optimising stroke prevention through the safe initiation and monitoring of Direct Oral Anticoagulants (DOACs) in patients with AF.
The sessions will cover:
- Assessing stroke and bleeding risk in AF
- Evidence-based DOAC prescribing
- Baseline checks and ongoing monitoring for safety and efficacy
- Practical tips for managing common challenges in primary care
- Managing common clinical scenarios and safety considerations
- The use of risk stratification tools to manage your atrial fibrillation population
This event aims to support consistent, high-quality anticoagulation management to protect patients from preventable strokes.
Speakers (2)
Jagjot Chahal
Cardiovascular Disease Prevention Lead PharmacistBarts Health NHS Trust
Jagjot is a Cardiovascular Disease Prevention Lead Pharmacist and an alumnus of Chief Pharmaceutical Officer’s Clinical Fellowship at NHS England
Paul Wright
PharmacistBarts Health NHS Trust
Paul is Consultant Cardiovascular Pharmacist at Barts health NHS Trust with over 15 years experience in cardiology. He was previously co-chair of the UKCPA cardiology committee and Programme guardian for several CPPE cardiology topics. He has delivered several key note presentations to national and international audiences, with a passion for translating evidence-based guidelines into clinical practice
